Latest Updates
-
The New Wellness Souvenir: Why Travellers Are Returning Home With Healthy Habits Instead of Handicrafts -
Shravan 2026: These 5 Zodiac Signs May Get Lord Shiva's Special Blessings This Year -
Anupama Parameswaran Talks About Love, Control, and Finally Walking Away -
Migraine or Brain Tumour? The Headache Symptoms Doctors Say Not to Ignore -
OTT Releases This Week (10 To 17 August): What To Stream On Netflix, Prime, JioHotstar, Zee5 And SonyLIV -
Throwback Thursday: On Sridevi’s 63rd Birth Anniversary, Movies That Made Her Bollywood’s First Lady Superstar -
Why Your Skincare Might Be Silently Damaging Your Skin's pH Balance -
Are Artificial Sweeteners Safe For Diabetics? The Truth About Sugar-Free Alternatives -
Skipping Rice To Avoid Diabetes? Debunking The Common Myth People Still Believe -
Recurring Chest Infections: Expert Explains If It Could Be a Sign of Lung Cancer?
Antibiotics Treating Cystic Fibrosis Can Be Dangerous, Know The Reasons
One of the major side-effects of antibiotics is explained here. Read on to know more.
A powerful class of antibiotics used to bring relief to people with cystic fibrosis (CF) could also increase the risk of permanent hearing loss, besides kidney damage, a study has found.
Aminoglycoside antibiotics is used by approximately 70,000 people worldwide who inherited the chronic disease that affects mostly the lungs, but also the pancreas, liver, kidneys and intestine.
The findings showed that patients who were administered a high dose of the antibiotics to reduce their respiratory infections were 4.79 times more likely to experience permanent hearing loss.

A situation that could further worsen due to isolation, depression and cognitive decline in such patients.
Aminoglycosides inhibit bacterial protein synthesis and is necessary to clear life-threatening infections, but it can also degrade auditory function in the inner ear as well as kidney function.

"Preventing or ameliorating the effects of permanent (hearing loss) is crucial for patients with CF who already have a significantly compromised quality of life due to the disease," said lead author Angela Garinis, research associate at Oregon Health and Science University in the US.
For the study, published in the Journal of Cystic Fibrosis, the team examined the medical records of 81 CF patients, aged 15 to 63 years, grouping them into four quartiles based on the cumulative dosage of aminoglycoside antibiotics administered intravenously.

It is imperative for physicians to routinely monitor hearing in any patient receiving aminoglycosides intravenously, the study said.
Further, physicians treating patients with CF should consider alternative strategies for treating the symptoms of respiratory infections associated with the disease, the researchers suggested.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications